Abingdon Health Plc (LON:ABDX – Get Free Report)’s stock price traded up 1% during mid-day trading on Monday . The company traded as high as GBX 8 ($0.10) and last traded at GBX 7.50 ($0.09). 176,447 shares were traded during trading, an increase of 22% from the average session volume of 144,485 shares. The stock had previously closed at GBX 7.42 ($0.09).
Abingdon Health Trading Down 3.4 %
The company’s 50 day simple moving average is GBX 7.80 and its two-hundred day simple moving average is GBX 8.45. The company has a debt-to-equity ratio of 46.64, a current ratio of 1.95 and a quick ratio of 1.96. The company has a market cap of £14.02 million, a PE ratio of -17.61 and a beta of 0.13.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.
Featured Articles
- Five stocks we like better than Abingdon Health
- Insider Buying Explained: What Investors Need to Know
- Nebius Group: NVIDIA’s Investment Sparks All-Time Highs
- Expert Stock Trading Psychology Tips
- SoFi Stock Rallying Strong in the Last 5 Days—What’s Driving It?
- How to Evaluate a Stock Before Buying
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
